如何为IIIC期或IV期卵巢癌患者选择新辅助化疗或初次肿瘤细胞减灭术 - Suppr

Suppr

超能文献

How to Select Neoadjuvant Chemotherapy or Primary Debulking Surgery in Patients With Stage IIIC or IV Ovarian Carcinoma.

作者信息

Vergote Ignace B, Van Nieuwenhuysen Els, Vanderstichele Adriaan

机构信息

Leuven Cancer Institute, KU Leuven, Leuven, Belgium.

出版信息

J Clin Oncol. 2016 Nov 10;34(32):3827-3828. doi: 10.1200/JCO.2016.69.7458. Epub 2016 Sep 30.

DOI:10.1200/JCO.2016.69.7458

PMID:27646940

Abstract

摘要

相似文献

How to Select Neoadjuvant Chemotherapy or Primary Debulking Surgery in Patients With Stage IIIC or IV Ovarian Carcinoma.如何为IIIC期或IV期卵巢癌患者选择新辅助化疗或初次肿瘤细胞减灭术

J Clin Oncol. 2016 Nov 10;34(32):3827-3828. doi: 10.1200/JCO.2016.69.7458. Epub 2016 Sep 30.

Survival outcomes after extensive cytoreductive surgery and selective neoadjuvant chemotherapy according to institutional criteria in bulky stage IIIC and IV epithelial ovarian cancer.根据机构标准，对晚期IIIC期和IV期上皮性卵巢癌进行广泛细胞减灭术和选择性新辅助化疗后的生存结果。

J Gynecol Oncol. 2017 Jul;28(4):e48. doi: 10.3802/jgo.2017.28.e48.

Platinum-Based Neoadjuvant Chemotherapy versus Primary Surgery in Ovarian Carcinoma International Federation of Gynecology and Obstetrics Stages IIIc and IV: A Systematic Review and Meta-Analysis.铂类药物为基础的新辅助化疗与卵巢癌国际妇产科联合会分期 IIIc 和 IV 期的初次手术治疗：系统评价和荟萃分析。

Gynecol Obstet Invest. 2018;83(3):209-219. doi: 10.1159/000485618. Epub 2017 Dec 21.

A Comparison of Survival Outcomes in Advanced Serous Ovarian Cancer Patients Treated With Primary Debulking Surgery Versus Neoadjuvant Chemotherapy.原发性肿瘤细胞减灭术与新辅助化疗治疗晚期浆液性卵巢癌患者的生存结果比较

Int J Gynecol Cancer. 2017 May;27(4):668-674. doi: 10.1097/IGC.0000000000000946.

Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.晚期卵巢癌行初次肿瘤细胞减灭术或新辅助化疗后间隔减瘤术。

Eur J Cancer. 2011 Sep;47 Suppl 3:S88-92. doi: 10.1016/S0959-8049(11)70152-6.

Primary debulking surgery versus neo-adjuvant chemotherapy in stage III/IV ovarian cancer: Comparison of perioperative morbidity and survival data in Pakistani women.原发性减瘤手术与新辅助化疗治疗Ⅲ/Ⅳ期卵巢癌：巴基斯坦女性围手术期发病率及生存数据比较

J Pak Med Assoc. 2015 Mar;65(3):306-9.

[Ⅱ.Comparison between Upfront Primary Debulking Surgery and Interval Debulking Surgery Following Neoadjuvant Chemotherapy for Primary Treatment of Ovarian Cancer].[Ⅱ. 卵巢癌初始治疗中，新辅助化疗后直接进行的初次肿瘤细胞减灭术与间隔性肿瘤细胞减灭术的比较]

Gan To Kagaku Ryoho. 2019 Feb;46(2):236-239.

Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?晚期IIIC期卵巢癌、输卵管癌和腹膜癌的最佳初始治疗：在初次肿瘤细胞减灭术中进行完全肉眼切除或新辅助化疗是仅有的选择吗？

Gynecol Oncol. 2017 Apr;145(1):15-20. doi: 10.1016/j.ygyno.2017.02.023. Epub 2017 Feb 21.

Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: A Single-Institution Experience and a Review of the Literature.晚期卵巢癌的新辅助化疗：单机构经验及文献综述

Oncology. 2016;91(4):211-216. doi: 10.1159/000447743. Epub 2016 Aug 3.

Laparoscopy Compared With Laparotomy for Debulking Ovarian Cancer After Neoadjuvant Chemotherapy.

Obstet Gynecol. 2017 Aug;130(2):469-470. doi: 10.1097/AOG.0000000000002183.

引用本文的文献

Assessment of Intraoperative Scoring Systems for Predicting Cytoreduction Outcome in Peritoneal Metastatic Disease: A Systematic Review and Meta-analysis.评估预测腹膜转移疾病细胞减灭术结局的术中评分系统：系统评价和荟萃分析。

Ann Surg Oncol. 2024 Oct;31(10):7165-7183. doi: 10.1245/s10434-024-15629-7. Epub 2024 Jun 25.

Prediction of Surgical Outcome in Advanced Ovarian Cancer by Imaging and Laparoscopy: A Narrative Review.通过影像学和腹腔镜检查预测晚期卵巢癌的手术结果：一项叙述性综述

Cancers (Basel). 2023 Mar 22;15(6):1904. doi: 10.3390/cancers15061904.

Surgery in Advanced Ovary Cancer: Primary versus Interval Cytoreduction.晚期卵巢癌手术：初次减瘤术与间隔期减瘤术

Diagnostics (Basel). 2022 Apr 14;12(4):988. doi: 10.3390/diagnostics12040988.

Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer.新辅助化疗在手术前与手术后化疗用于晚期卵巢上皮癌的初始治疗。

Cochrane Database Syst Rev. 2021 Jul 30;7(7):CD005343. doi: 10.1002/14651858.CD005343.pub6.

Dense hyperthermic intraperitoneal chemotherapy with cisplatin in patients with stage III serous epithelial ovarian cancer: a retrospective study.III 期浆液性上皮性卵巢癌患者应用顺铂密集高热腹腔化疗的回顾性研究。

BMC Cancer. 2021 Jun 27;21(1):738. doi: 10.1186/s12885-021-08507-y.

Hypoxic isolated abdominal perfusion breaks through chemoresistance in recurrent FIGO stage IIIC and IV ovarian cancer.缺氧孤立性腹腔灌注突破复发性国际妇产科联盟（FIGO）IIIC期和IV期卵巢癌的化疗耐药性。

Mol Clin Oncol. 2021 Jun;14(6):129. doi: 10.3892/mco.2021.2291. Epub 2021 Apr 27.

Proteomic Studies on the Management of High-Grade Serous Ovarian Cancer Patients: A Mini-Review.高级别浆液性卵巢癌患者管理的蛋白质组学研究：一项小型综述。

Cancers (Basel). 2021 Apr 25;13(9):2067. doi: 10.3390/cancers13092067.

Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.晚期卵巢上皮癌初始治疗中化疗与手术的比较

Cochrane Database Syst Rev. 2021 Feb 5;2(2):CD005343. doi: 10.1002/14651858.CD005343.pub5.

A Prediction Model for Optimal Primary Debulking Surgery Based on Preoperative Computed Tomography Scans and Clinical Factors in Patients With Advanced Ovarian Cancer: A Multicenter Retrospective Cohort Study.基于术前计算机断层扫描和晚期卵巢癌患者临床因素的最佳初次肿瘤细胞减灭术预测模型：一项多中心回顾性队列研究

Front Oncol. 2021 Jan 7;10:611617. doi: 10.3389/fonc.2020.611617. eCollection 2020.

First-Line Management of Advanced High-Grade Serous Ovarian Cancer.高级别浆液性卵巢癌的一线治疗。

Curr Oncol Rep. 2020 Jun 4;22(6):64. doi: 10.1007/s11912-020-00933-8.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验